Comprehensive lipidomic, metabolomic and proteomic profiling reveals the role of immune system in vitiligo
- 12 March 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 44 (7) , E216-E223
Abstract
Purpose Vitiligo is a common depigmentation disorder resulting from destruction of melanocytes, with both genetic and environmental influences. Although genomic analyses have been performed to investigate the pathogenesis of vitiligo, the lipidomics, metabolomics and proteomics of serum have not been reported and the role of small molecules and serum proteins in vitiligo remains unknown. Experimental design To study the metabolite and protein profiles in vitiligo and healthy controls, plasma samples from 60 participants (29 vitiligo and 31 healthy) were analyzed. Untargeted lipidomics, metabolomics and iTRAQ‐based proteomics were performed using ultra‐performance liquid chromatography‐tandem mass spectrometry. In addition, to validate differentially expressed metabolites in vitiligo patients, plasma enzyme‐linked immunosorbent assay was performed. Results We identified differential expression of several metabolites and proteins involved in the immune system. Among these metabolites and proteins, lysophosphatidylcholine (lysoPC, LPC), platelet‐activating factor (PAF), sn‐glycerol‐3‐phosphocholine (GPC), succinic acid, C‐X‐C motif chemokine 4 (CXCL4) and CXCL7 were significantly elevated in the plasma of vitiligo patients, while aspartate was down‐regulated. Conclusions and clinical relevance Our study characterizes several serum metabolites and proteins which could be potential candidate biomarkers in vitiligo and provides a comprehensive insight into the role of immune system and aspartate metabolism in vitiligo.Keywords
Funding Information
- National Natural Science Foundation of China (31800626)
This publication has 24 references indexed in Scilit:
- Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligoNature Genetics, 2012
- Circulating Platelet-Activating Factor Is Primarily Cleared by Transport, Not Intravascular Hydrolysis by Lipoprotein-Associated Phospholipase A 2 / PAF AcetylhydrolaseCirculation Research, 2011
- Clinical Pattern of Vitiligo in LibyaInternational Journal of Dermatology, 2007
- Late onset vitiligo: A study of 182 patientsInternational Journal of Dermatology, 2004
- Signaling Mechanism Underlying COX-2 Induction by LysophosphatidylcholineBiochemical and Biophysical Research Communications, 2001
- CYCLOOXYGENASES 1 AND 2Annual Review of Pharmacology and Toxicology, 1998
- Induction of cyclooxygenase-2 in human umbilical vein endothelial cells by lysophosphatidylcholine.Journal of Clinical Investigation, 1995
- Vitiligo and Other Diseases: Coexistence or True Association?Dermatology, 1994
- Platelet Activating Factor (PAF)Drugs, 1991
- Clinical Pattern of Vitiligo in LibyaInternational Journal of Dermatology, 1985